BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38012744)

  • 1. Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer.
    Lin X; Chen JD; Wang CY; Cai Z; Zhan R; Yang C; Zhang LY; Li LY; Xiao Y; Chen MK; Wu M
    Genome Biol; 2023 Nov; 24(1):268. PubMed ID: 38012744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion.
    Lu C; Paschall AV; Shi H; Savage N; Waller JL; Sabbatini ME; Oberlies NH; Pearce C; Liu K
    J Natl Cancer Inst; 2017 Jan; 109(6):. PubMed ID: 28131992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling.
    Hu J; Shan Y; Ma J; Pan Y; Zhou H; Jiang L; Jia L
    Int J Cancer; 2019 Jul; 145(2):450-460. PubMed ID: 30613961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-193a targets MLL1 mRNA and drastically decreases MLL1 protein production: Ectopic expression of the miRNA aberrantly lowers H3K4me3 content of the chromatin and hampers cell proliferation and viability.
    Sengupta D; Deb M; Kar S; Parbin S; Pradhan N; Patra SK
    Gene; 2019 Jul; 705():22-35. PubMed ID: 31005612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
    Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
    Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased mixed lineage leukemia 1 is involved in endometriosis-related infertility.
    Wen X; Xiong Y; Liu H; Geng T; Jin L; Zhang M; Ma L; Zhang Y
    J Mol Endocrinol; 2021 Jan; 66(1):45-57. PubMed ID: 33151904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The same pocket in menin binds both MLL and JUND but has opposite effects on transcription.
    Huang J; Gurung B; Wan B; Matkar S; Veniaminova NA; Wan K; Merchant JL; Hua X; Lei M
    Nature; 2012 Feb; 482(7386):542-6. PubMed ID: 22327296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the H3K4 methyltransferase MLL1/WDR5 complex attenuates renal senescence in ischemia reperfusion mice by reduction of p16
    Shimoda H; Doi S; Nakashima A; Sasaki K; Doi T; Masaki T
    Kidney Int; 2019 Nov; 96(5):1162-1175. PubMed ID: 31570196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of the Epigenome by MLL1 Links Early-Life Environmental Exposures to Prostate Cancer Risk.
    Wang Q; Trevino LS; Wong RL; Medvedovic M; Chen J; Ho SM; Shen J; Foulds CE; Coarfa C; O'Malley BW; Shilatifard A; Walker CL
    Mol Endocrinol; 2016 Aug; 30(8):856-71. PubMed ID: 27219490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone methyltransferase MLL1 drives renal tubular cell apoptosis by p53-dependent repression of E-cadherin during cisplatin-induced acute kidney injury.
    Zhang C; Guan Y; Zou J; Yang X; Bayliss G; Zhuang S
    Cell Death Dis; 2022 Sep; 13(9):770. PubMed ID: 36068197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pax6 associates with H3K4-specific histone methyltransferases Mll1, Mll2, and Set1a and regulates H3K4 methylation at promoters and enhancers.
    Sun J; Zhao Y; McGreal R; Cohen-Tayar Y; Rockowitz S; Wilczek C; Ashery-Padan R; Shechter D; Zheng D; Cvekl A
    Epigenetics Chromatin; 2016; 9(1):37. PubMed ID: 27617035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting MLL1-WDR5 interaction ameliorates neuropathic allodynia by attenuating histone H3 lysine 4 trimethylation-dependent spinal mGluR5 transcription.
    Lin TB; Lai CY; Hsieh MC; Ho YC; Wang HH; Yang PS; Cheng JK; Chen GD; Ng SC; Peng HY
    Pain; 2020 Sep; 161(9):1995-2009. PubMed ID: 32345914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automethylation activities within the mixed lineage leukemia-1 (MLL1) core complex reveal evidence supporting a "two-active site" model for multiple histone H3 lysine 4 methylation.
    Patel A; Vought VE; Swatkoski S; Viggiano S; Howard B; Dharmarajan V; Monteith KE; Kupakuwana G; Namitz KE; Shinsky SA; Cotter RJ; Cosgrove MS
    J Biol Chem; 2014 Jan; 289(2):868-84. PubMed ID: 24235145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLL1, a H3K4 methyltransferase, regulates the TNFα-stimulated activation of genes downstream of NF-κB.
    Wang X; Zhu K; Li S; Liao Y; Du R; Zhang X; Shu HB; Guo AY; Li L; Wu M
    J Cell Sci; 2012 Sep; 125(Pt 17):4058-66. PubMed ID: 22623725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA PM maintains cerebellar synaptic integrity and Cbln1 activation via Pax6/Mll1-mediated H3K4me3.
    Jin Y; Zhang B; Lu J; Song Y; Wang W; Zhang W; Shao F; Gong M; Wang M; Liang X; Li S; Zhang Z; Shan G; Wang X
    PLoS Biol; 2021 Jun; 19(6):e3001297. PubMed ID: 34111112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL1 promotes myogenesis by epigenetically regulating Myf5.
    Cai S; Zhu Q; Guo C; Yuan R; Zhang X; Nie Y; Chen L; Fang Y; Chen K; Zhang J; Mo D; Chen Y
    Cell Prolif; 2020 Feb; 53(2):e12744. PubMed ID: 31840352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia.
    Cao F; Townsend EC; Karatas H; Xu J; Li L; Lee S; Liu L; Chen Y; Ouillette P; Zhu J; Hess JL; Atadja P; Lei M; Qin ZS; Malek S; Wang S; Dou Y
    Mol Cell; 2014 Jan; 53(2):247-61. PubMed ID: 24389101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Histone Methyltransferase MLL1 Directs Macrophage-Mediated Inflammation in Wound Healing and Is Altered in a Murine Model of Obesity and Type 2 Diabetes.
    Kimball AS; Joshi A; Carson WF; Boniakowski AE; Schaller M; Allen R; Bermick J; Davis FM; Henke PK; Burant CF; Kunkel SL; Gallagher KA
    Diabetes; 2017 Sep; 66(9):2459-2471. PubMed ID: 28663191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wnt-Driven Mll1 Epigenome Regulates Salivary Gland and Head and Neck Cancer.
    Zhu Q; Fang L; Heuberger J; Kranz A; Schipper J; Scheckenbach K; Vidal RO; Sunaga-Franze DY; Müller M; Wulf-Goldenberg A; Sauer S; Birchmeier W
    Cell Rep; 2019 Jan; 26(2):415-428.e5. PubMed ID: 30625324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hyper-activation of transcriptional enhancers in breast cancer.
    Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
    Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.